It has been a few years since we last spoke to you. Can you give our readers a refresher about the company, and how it got started? Mr. Kanter: Yes, we’ve actually been around in one form or another ...

Despite missing Q2 guidance, PubMatic shows strong growth potential in key areas like omnichannel video and mobile apps.

Financially, Rhythm has $319.1 million in cash, but may need to raise more funds within the next 12 months. See why I rate ...

NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) recently announced a pivotal shift in its board with the appointment of Luba ...

Q3 2024 Earnings Call Transcript September 17, 2024 Operator: Good morning. My name is Nadia, and I’ll be your conference ...

Earlyworks Co., Ltd. (NASDAQ: ELWS) (“Earlyworks” or the “Company”), a blockchain solution provider headquartered in Taito-ku ...

Features of the group include: Insights through his concentrated portfolio of value stocks, timely updates on stock picks, a ...

("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO) is pleased to announce the promotion of Francesco D'Alessio to the role of Chief Commercial Officer, effective immediately. With Largo since 2019, ...

Nvidia (NASDAQ:NVDA) is at the center of the current AI arms race, as cloud providers, hyperscalers, and enterprises scramble ...

The company also acquired the rights to Ketamir, which, in layman’s terms, is a potential derivative of the antidepressant ketamine that has shown indications of having fewer side effects, working ...

Rocket Lab’s advancements with its Neutron rocket and expanding capabilities contribute to its long-term value. Find out more ...

CRISPR Therapeutics' stock may seem boring due to slow FDA trial and rollout process, but it's a strong long-term investment.